Skip to content
akaturk Academic measurement

Article detail · 2017

CHRODIS criteria applied to the MASK (MACVIA-ARIA Sentinel NetworK) Good Practice in allergic rhinitis: a SUNFRAIL report

Journal

Clinical and Translational Allergy
OpenAlex Open access · gold SJR Q2 JCR Q2 Citations 46 Top 10% Percentile 96.5% FWCI 5.22
Year
2017
Type
article

Data source split

  • YÖKSİS venue Clinical and Translational Allergy
  • OpenAlex OpenAlex enrichment (abstract, citations, topics)

Abstract

OpenAlex · English

A Good Practice is a practice that works well, produces good results, and is recommended as a model. MACVIA-ARIA Sentinel Network (MASK), the new Allergic Rhinitis and its Impact on Asthma (ARIA) initiative, is an example of a Good Practice focusing on the implementation of multi-sectoral care pathways using emerging technologies with real life data in rhinitis and asthma multi-morbidity. The European Union Joint Action on Chronic Diseases and Promoting Healthy Ageing across the Life Cycle (JA-CHRODIS) has developed a checklist of 28 items for the evaluation of Good Practices. SUNFRAIL (Reference Sites Network for Prevention and Care of Frailty and Chronic Conditions in community dwelling persons of EU Countries), a European Union project, assessed whether MASK is in line with the 28 items of JA-CHRODIS. A short summary was proposed for each item and 18 experts, all members of ARIA and SUNFRAIL from 12 countries, assessed the 28 items using a Survey Monkey-based questionnaire. A visual analogue scale (VAS) from 0 (strongly disagree) to 100 (strongly agree) was used. Agreement equal or over 75% was observed for 14 items (50%). MASK is following the JA-CHRODIS recommendations for the evaluation of Good Practices.

Topics

Citations

OpenAlex cited_by_count. Not a WoS or Scopus citation count; those sources have no separate column here.

46 citations

OpenAlex cited_by_count (cache / database)

16 publications in the local catalog that cite this work (OpenAlex reference match; not the full global list).

  1. Allergic Rhinitis and its Impact on Asthma (ARIA) Phase 4 (2018): Change management in allergic rhinitis and asthma multimorbidity using mobile technology 2019 Citations 168 · OpenAlex
  2. MASK 2017: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma multimorbidity using real-world-evidence 2018 Citations 139 · OpenAlex
  3. Guidance to 2018 good practice: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma 2019 Citations 132 · OpenAlex
  4. Guidance to 2018 good practice: ARIA digitally-enabled, integrated, person-centred care for rhinitis and asthma 2019 Citations 132 · OpenAlex
  5. Adherence to treatment in allergic rhinitis using mobile technology. The MASK Study 2019 Citations 99 · OpenAlex
  6. Adherence to treatment in allergic rhinitis using mobile technology. The MASK Study 2018 Citations 99 · OpenAlex
  7. Daily allergic multimorbidity in rhinitis using mobile technology: A novel concept of the MASK study 2018 Citations 80 · OpenAlex
  8. Digitally‐enabled, patient‐centred care in rhinitis and asthma multimorbidity: The ARIA‐MASK‐air ® approach 2023 Citations 56 · OpenAlex
  9. Digitally‐enabled, patient‐centred care in rhinitis and asthma multimorbidity: The ARIA‐MASK‐air®approach 2023 Citations 56 · OpenAlex
  10. Digitally‐enabled, patient‐centred care in rhinitis and asthma multimorbidity: The ARIA‐MASK‐air®approach 2023 Citations 56 · OpenAlex

Authors

No author information.